儿童和青少年罕见肿瘤虚拟会诊系统--欧洲儿童罕见肿瘤合作研究小组(EXPeRT)的一项倡议

Dominik T. Schneider , Andrea Ferrari , Daniel Orbach , Calogero Virgone , Yves Reguerre , Jan Godzinski , Ewa Bien , Jelena Roganovic , Nuno Reis Farinha , Tal Ben-Ami , Teresa Stachowicz-Stencel , Tabea Blessing , Antje Redlich , Apostolos Pourtsidis , Kris Ann P. Schultz , Ines B. Brecht , Gianni Bisogno
{"title":"儿童和青少年罕见肿瘤虚拟会诊系统--欧洲儿童罕见肿瘤合作研究小组(EXPeRT)的一项倡议","authors":"Dominik T. Schneider ,&nbsp;Andrea Ferrari ,&nbsp;Daniel Orbach ,&nbsp;Calogero Virgone ,&nbsp;Yves Reguerre ,&nbsp;Jan Godzinski ,&nbsp;Ewa Bien ,&nbsp;Jelena Roganovic ,&nbsp;Nuno Reis Farinha ,&nbsp;Tal Ben-Ami ,&nbsp;Teresa Stachowicz-Stencel ,&nbsp;Tabea Blessing ,&nbsp;Antje Redlich ,&nbsp;Apostolos Pourtsidis ,&nbsp;Kris Ann P. Schultz ,&nbsp;Ines B. Brecht ,&nbsp;Gianni Bisogno","doi":"10.1016/j.ejcped.2023.100137","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Very rare tumors (VRTs) in children and adolescents are orphan diseases defined by an annual incidence of &lt;2/1000,000. For a long time, VRTs have been outside of clinical and research groups in the field of pediatric oncology. As a result, exchange of experience and development of therapeutic standards have not been promoted. After the foundation of several national VRT working groups and the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT), a virtual consultation system (VCS) has been established, which specifically aimed at facilitating access to clinical consultation in complicated cases of VRTs.</p></div><div><h3>Methods</h3><p>The VCS has been open to physicians. After initial registration, they can present VRT patients free of charge. Patient consent and data pseudonymization were mandatory. Within the VCS, disease specific interdisciplinary panel discussions with at least three experts from the EXPeRT group and partners have been opened, and at the end of the discussion, a written summary and recommendation was provided.</p></div><div><h3>Results</h3><p>Between Mai 2017 and March 2023, 160 cases from 27 countries (20 European, 7 non-European) have been discussed in the VCS. The most common diagnoses were adrenocortical carcinoma, malignant skin tumors and malignant ovarian tumors. In a survey three months after panel discussion, more than 90% of requesting physicians evaluated the VCS to be easy to use, helpful and to have a significant impact on patient management.</p></div><div><h3>Conclusion</h3><p>A VCS may provide significant assistance in the management of children and adolescents with VRTs. Furthermore, it may help to overcome inequalities in access to adequate treatment in countries with lower health care system resources or without established VRT study groups. Therefore, EXPeRT will continue to support the VCS. For this purpose, the VRT panels have been integrated into the Clinical Patient Management System (CPMS) within the European Reference Network Initiative (ERN PAedCan).</p></div>","PeriodicalId":94314,"journal":{"name":"EJC paediatric oncology","volume":"3 ","pages":"Article 100137"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772610X23001356/pdfft?md5=40889d1fba9c149920fbce54ebc78b77&pid=1-s2.0-S2772610X23001356-main.pdf","citationCount":"0","resultStr":"{\"title\":\"A virtual consultation system for very rare tumors in children and adolescents – an initiative of the European Cooperative Study Group in Rare Tumors in Children (EXPeRT)\",\"authors\":\"Dominik T. Schneider ,&nbsp;Andrea Ferrari ,&nbsp;Daniel Orbach ,&nbsp;Calogero Virgone ,&nbsp;Yves Reguerre ,&nbsp;Jan Godzinski ,&nbsp;Ewa Bien ,&nbsp;Jelena Roganovic ,&nbsp;Nuno Reis Farinha ,&nbsp;Tal Ben-Ami ,&nbsp;Teresa Stachowicz-Stencel ,&nbsp;Tabea Blessing ,&nbsp;Antje Redlich ,&nbsp;Apostolos Pourtsidis ,&nbsp;Kris Ann P. Schultz ,&nbsp;Ines B. Brecht ,&nbsp;Gianni Bisogno\",\"doi\":\"10.1016/j.ejcped.2023.100137\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Very rare tumors (VRTs) in children and adolescents are orphan diseases defined by an annual incidence of &lt;2/1000,000. For a long time, VRTs have been outside of clinical and research groups in the field of pediatric oncology. As a result, exchange of experience and development of therapeutic standards have not been promoted. After the foundation of several national VRT working groups and the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT), a virtual consultation system (VCS) has been established, which specifically aimed at facilitating access to clinical consultation in complicated cases of VRTs.</p></div><div><h3>Methods</h3><p>The VCS has been open to physicians. After initial registration, they can present VRT patients free of charge. Patient consent and data pseudonymization were mandatory. Within the VCS, disease specific interdisciplinary panel discussions with at least three experts from the EXPeRT group and partners have been opened, and at the end of the discussion, a written summary and recommendation was provided.</p></div><div><h3>Results</h3><p>Between Mai 2017 and March 2023, 160 cases from 27 countries (20 European, 7 non-European) have been discussed in the VCS. The most common diagnoses were adrenocortical carcinoma, malignant skin tumors and malignant ovarian tumors. In a survey three months after panel discussion, more than 90% of requesting physicians evaluated the VCS to be easy to use, helpful and to have a significant impact on patient management.</p></div><div><h3>Conclusion</h3><p>A VCS may provide significant assistance in the management of children and adolescents with VRTs. Furthermore, it may help to overcome inequalities in access to adequate treatment in countries with lower health care system resources or without established VRT study groups. Therefore, EXPeRT will continue to support the VCS. For this purpose, the VRT panels have been integrated into the Clinical Patient Management System (CPMS) within the European Reference Network Initiative (ERN PAedCan).</p></div>\",\"PeriodicalId\":94314,\"journal\":{\"name\":\"EJC paediatric oncology\",\"volume\":\"3 \",\"pages\":\"Article 100137\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2772610X23001356/pdfft?md5=40889d1fba9c149920fbce54ebc78b77&pid=1-s2.0-S2772610X23001356-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EJC paediatric oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772610X23001356\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJC paediatric oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772610X23001356","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景儿童和青少年中的极罕见肿瘤(VRTs)是一种孤儿病,年发病率仅为 2/100,000。长期以来,VRT 一直游离于儿科肿瘤学领域的临床和研究小组之外。因此,经验交流和治疗标准的制定都没有得到促进。在几个国家的 VRT 工作组和欧洲儿科罕见肿瘤合作研究组(EXPeRT)成立之后,一个虚拟会诊系统(VCS)已经建立,其具体目标是为 VRT 复杂病例的临床会诊提供便利。首次注册后,他们可以免费为 VRT 患者提供服务。患者同意和数据化名是强制性的。在 VCS 中,至少有三名来自 EXPeRT 小组和合作伙伴的专家参与了针对特定疾病的跨学科小组讨论,讨论结束后,将提供一份书面总结和建议。最常见的诊断是肾上腺皮质癌、恶性皮肤肿瘤和恶性卵巢肿瘤。在小组讨论三个月后进行的一项调查中,超过 90% 的提出请求的医生认为 VCS 易于使用、很有帮助,并对患者管理产生了重大影响。此外,在医疗保健系统资源较少或没有建立 VRT 研究小组的国家,它还有助于克服在获得适当治疗方面存在的不平等现象。因此,EXPeRT 将继续支持 VCS。为此,VRT 小组已被纳入欧洲参考网络计划 (ERN PAedCan) 的临床患者管理系统 (CPMS)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
A virtual consultation system for very rare tumors in children and adolescents – an initiative of the European Cooperative Study Group in Rare Tumors in Children (EXPeRT)

Background

Very rare tumors (VRTs) in children and adolescents are orphan diseases defined by an annual incidence of <2/1000,000. For a long time, VRTs have been outside of clinical and research groups in the field of pediatric oncology. As a result, exchange of experience and development of therapeutic standards have not been promoted. After the foundation of several national VRT working groups and the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT), a virtual consultation system (VCS) has been established, which specifically aimed at facilitating access to clinical consultation in complicated cases of VRTs.

Methods

The VCS has been open to physicians. After initial registration, they can present VRT patients free of charge. Patient consent and data pseudonymization were mandatory. Within the VCS, disease specific interdisciplinary panel discussions with at least three experts from the EXPeRT group and partners have been opened, and at the end of the discussion, a written summary and recommendation was provided.

Results

Between Mai 2017 and March 2023, 160 cases from 27 countries (20 European, 7 non-European) have been discussed in the VCS. The most common diagnoses were adrenocortical carcinoma, malignant skin tumors and malignant ovarian tumors. In a survey three months after panel discussion, more than 90% of requesting physicians evaluated the VCS to be easy to use, helpful and to have a significant impact on patient management.

Conclusion

A VCS may provide significant assistance in the management of children and adolescents with VRTs. Furthermore, it may help to overcome inequalities in access to adequate treatment in countries with lower health care system resources or without established VRT study groups. Therefore, EXPeRT will continue to support the VCS. For this purpose, the VRT panels have been integrated into the Clinical Patient Management System (CPMS) within the European Reference Network Initiative (ERN PAedCan).

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
0
期刊最新文献
Potential of non-FDG PET radiotracers for paediatric patients with solid tumours New insights into hematopoietic cell transplantation in ALL: Who should be transplanted, when, and how Patients’, parents’, and survivors’ perspective about AI applications in pediatric oncology Enhancing pediatric oncology clinical trials through patient reported outcomes (PROs) A practical guide to apply AI in childhood cancer: Data collection and AI model implementation
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1